GLUE R&D Expenses
Monte Rosa Therapeutics Inc · R&D Expenses
GLUE R&D Expenses
Latest reported$170.69Mperiod ending
GLUE R&D Expenses ($7.35M → $170.69M)
Annual R&D Expenses
High-resolution chart · PNG
GLUE r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 141,500,000 | |
| 121,563,000 | |
| 105,050,000 | |
| 85,061,000 | |
| 57,155,000 | |
| 23,468,000 | |
| 7,350,000 |